The Latest in Critical Care, 10/30/23 (Issue #18)
Societies call for SEP-1 elimination; Amikacin for VAP (AMIKINHAL trial); Statins for Covid-19 pneumonia (REMAP-CAP trial)
The Infectious Diseases Society of America (IDSA), along with societies for emergency medicine physicians and hospitalists, are again speaking up about the ongoing policy experiment known as the Centers for Medicare and Medicaid Severe Sepsis/Septic Shock Management Bundle (SEP-1).
SEP-1 is a re…
Keep reading with a 7-day free trial
Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.